Although systemic or inhaled corticosteroids may result in clinical improvement in BPD, concerns about adverse neurodevelopmental outcomes from repeated and / or prolonged courses of dexamethasone for BPD (2) led to the reaffirmed (2014) American Academy of Pediatrics' policy statement discouraging the routine use of dexamethasone for BPD.